Back to our team
Oliver Freudenreich, MD
Director, MGH Psychosis Consultation Service
Professor of Clinical Psychiatry, Harvard Medical School · Co-Director, MGH Psychosis Clinical & Research Program
Dr. Freudenreich directs the consultation service and provides expert guidance for clinicians managing complex cases. His clinical work focuses on optimal psychopharmacologic treatment for schizophrenia, treatment-resistant psychosis, and psychiatric consultation for medically complex patients.
Areas of focus
Expertise brought to each consultation
- Schizophrenia and psychosis
- Clozapine treatment
- Treatment-resistant psychosis
- Medical-psychiatric complexity